Through Pleiotropic effects such as GnRH antagonist, 5-α reductase inhibitor of GV1001, we have confirmed improvements in International Prostate Symptom Score (IPSS), urination rate, reduced residual urine volume, and no side effects (sexual dysfunction) in clinical trials.